Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, Bloomberg News reported that AstraZeneca (NASDAQ: AZN) is in discussions ...

AstraZeneca is a global healthcare incumbent that's large, sprawling, and well financed -- at the end of its latest reported quarter, the U.K.-headquartered company had more than 4 billion British ...

Investing.com -- Summit Therapeutics (NASDAQ:SMMT) stock rose 5% on Thursday while AstraZeneca (NASDAQ:AZN) shares fell 2% following a Bloomberg report that the companies are in discussions for a ...

Since ADBA published its report on the role of green gases in December last year, the first unsubsidised biomethane plant has ...

In the most recent trading session, Stellantis (STLA) closed at $9.8, indicating a -4.95% shift from the previous trading day.

In a press release on June 13, 2025, AstraZeneca announced its entry into a strategic research collaboration with CSPC Pharmaceuticals Group, based in Shijiazhuang City, China (1). The two companies ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer. Tremelimumab ...

AstraZeneca’s rare disease firm Alexion is set to expand its genomic medicine portfolio with the acquisition of gene editing specialist LogicBio Therapeutics, in a deal worth approximately $68 ...

President Donald Trump is in Canada attending the Group of Seven summit and is expected to meet with several leaders from the world's largest economies amid rising tensions over his tariffs and ...